Oric Pharmaceuticals (ORIC)Orbimed Advisors LLC reduced its stake -679K shares

2.02M

Shares reported · -679K vs prior quarter

0.41%

Disclosed portfolio weight

$21.8M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 18, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“ORIC Pharmaceuticals, Inc. (the “Company”) amended and restated its 2020 Equity Incentive Plan (the “A&R 2020 Equity Incentive Plan”), effective as of June 18, 2026 upon approval by the stockholders of the Company at the Annual Meeting (as defined below).”
2. Jul 28, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective July 28, 2026, the Board of Directors (the “Board”) of ORIC Pharmaceuticals, Inc. (the “Company”) approved the ORIC Pharmaceuticals, Inc. Amended and Restated 2022 Inducement Equity Incentive Plan (as amended, the “Inducement Plan”), in order to increase the number of shares reserved for issuance under the Inducement Plan.”
3. Aug 3, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Sep 24, 2026Insider · 1 personInsiders: 2 sales (~$8K)
2. Sep 28, 2026InsiderCFO sold ~$181K of ORIC shares in the open market
3. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$87K)

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Oric Pharmaceuticals

For Oric Pharmaceuticals, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ORIC page.

How this filing works

• SEC Form 13F

Other disclosures at Oric Pharmaceuticals

• SEC Form 4Oct 2, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 29, 2026
• SEC Form 4Sep 25, 2026
• SEC Form 4Sep 25, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its ORIC page.